Datos del Documento
Por favor, use este identificador para citar o enlazar este documento:
https://ria.asturias.es/RIA/handle/123456789/382Registro de Metadatos Completo
| Campo Dublin Core | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Fernández Martín, Luis | - |
| dc.date.accessioned | 2010-06-03T12:03:41Z | - |
| dc.date.available | 2010-06-03T12:03:41Z | - |
| dc.date.issued | 2009 | - |
| dc.identifier.citation | Nat Rev Nephrol.2009;5:307-308 | eng |
| dc.identifier.issn | 1759-507X | - |
| dc.identifier.uri | https://ria.asturias.es/RIA/handle/123456789/382 | - |
| dc.description.abstract | Cinacalcet is an effective treatment for secondary hyperparathyroidism in patients on dialysis. Until now, no randomized, placebo-controlled, long-term trial has tested this drug in individuals with chronic kidney disease who are not receiving dialysis | eng |
| dc.description.sponsorship | CKD-MBD experimental and epidemiological studies have received support from FICYT (IB05-060), ISCIII-Retics-RD06, REDinREN (16/06), Fundación Renal Iñigo Alvarez de Toledo, Amgen, and Fresenius | eng |
| dc.language.iso | eng | eng |
| dc.publisher | Nature Pub. Group | eng |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by/3.0/es/ | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/deed.es | eng |
| dc.subject | Hyperparathyroidism | eng |
| dc.subject | Secondary/drug therapy | eng |
| dc.subject | Secondiary/etiology | eng |
| dc.subject | Hyperphosphatemia/drug therapy | eng |
| dc.title | Should cinacalcet be used in patients who are not on dialysis? | eng |
| dc.type | article | eng |
| Aparece en las colecciones: | Sanidad | |
Archivos en este documento:
| Fichero | Tamaño | Formato | |
|---|---|---|---|
| Archivo.pdf | 282.18 kB | Adobe PDF | Ver/Abrir |
Este documento está sujeto a una licencia Creative Commons:
Licencia Creative Commons